RT @flaskworks: @InvestorTurf Cramer taught @adamfeuerstein how to manipulate markets which led to $NWBO's collapse, in combination with sp…

@CliffordAsness Never trade stocks like $GME or $AMC but own companies such as $NWBO which are building durable competitive advantage in markets that skew towards being natural monopolies. https://t.co/UbQi4GbIF9 https://t.co/TEP9AGjsxH https://t.co/BOTN

RT @flaskworks: @InvestorTurf Cramer taught @adamfeuerstein how to manipulate markets which led to $NWBO's collapse, in combination with sp…

@InvestorTurf Cramer taught @adamfeuerstein how to manipulate markets which led to $NWBO's collapse, in combination with spoofing, on 5/10/2022 before topline data release. More information on life-saving DCVax in @JAMAOnc @Nature. https://t.co/UbQi4GbIF

Phase 3 results: “11/17/22 Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma A Phase 3 Prospective Externally Controlled Cohort Trial” https://

$nwbo $djt #sdny #aviperry #adamfeuerstein #cohenmilstein FLIPPED AAG to defendant. Puke? https://t.co/Z8MM7UaShh Spoofing case/belies naked short attack https://t.co/4tfnBnRRyZ JAMA 70+ neuroonocolgists https://t.co/3TFiuDgCk3 UK APPROVAL pending http

HAVANA SYNDROME ATTACKS Electromagnetic "Skeleton Key" signal to signal hacking Cyber Attacks with global targeting capabilities! AMERICA'S GPS CAN BE MODIFIED TO CONNECT TO YOUR WIRELESS ELECTRONICS BY CONNECTING TO THE WIRELESS SIGNALS PRODUCED BY THE W

RT @Hspooner665: Connecting the dots before MHRA approval, 2 Peer reviewed publications and production ready to go! $NWBO🤟😄 1. JAMA Onco…

RT @alphavestcap: $nwbo @alphavestcap @Hspooner665 Connecting the dots before MHRA approval, 1. JAMA Oncology-Peer reviewed 2 Peer r…

RT @hoffmann6383: @DuabaiSunny I don't think Poly-ICLC has shown any effectiveness solo, or at least we don't have that data. DCVax-L dat…

@DuabaiSunny I don't think Poly-ICLC has shown any effectiveness solo, or at least we don't have that data. DCVax-L data can be found here: https://t.co/M53DdAw0kG "In this study, adding DCVax-L to SOC was associated with a clinically meaningful and sta

RT @Hspooner665: Connecting the dots before MHRA approval, 2 Peer reviewed publications and production ready to go! $NWBO🤟😄 1. JAMA Onco…

$nwbo @alphavestcap @Hspooner665 Connecting the dots before MHRA approval, 1. JAMA Oncology-Peer reviewed 2 Peer reviewed publications and production ready to go! 3. Install Flaskworks automated production facility https://t.co/bhUDKROm2Z… https

$nwbo @alphavestcap @Hspooner665 Connecting the dots before MHRA approval, 1. JAMA Oncology-Peer reviewed 2 Peer reviewed publications and production ready to go! 3. Install Flaskworks automated production facility https://t.co/bhUDKROm2Z… https

#dcvax $nwbo #gbm

RT @Hspooner665: Connecting the dots before MHRA approval, 2 Peer reviewed publications and production ready to go! $NWBO🤟😄 1. JAMA Onco…

RT @Hspooner665: Connecting the dots before MHRA approval, 2 Peer reviewed publications and production ready to go! $NWBO🤟😄 1. JAMA Onco…

RT @Hspooner665: Connecting the dots before MHRA approval, 2 Peer reviewed publications and production ready to go! $NWBO🤟😄 1. JAMA Onco…

RT @Hspooner665: Connecting the dots before MHRA approval, 2 Peer reviewed publications and production ready to go! $NWBO🤟😄 1. JAMA Onco…

RT @Hspooner665: Connecting the dots before MHRA approval, 2 Peer reviewed publications and production ready to go! $NWBO🤟😄 1. JAMA Onco…

RT @Hspooner665: Connecting the dots before MHRA approval, 2 Peer reviewed publications and production ready to go! $NWBO🤟😄 1. JAMA Onco…

RT @Hspooner665: Connecting the dots before MHRA approval, 2 Peer reviewed publications and production ready to go! $NWBO🤟😄 1. JAMA Onco…

RT @Hspooner665: Connecting the dots before MHRA approval, 2 Peer reviewed publications and production ready to go! $NWBO🤟😄 1. JAMA Onco…

RT @Hspooner665: Connecting the dots before MHRA approval, 2 Peer reviewed publications and production ready to go! $NWBO🤟😄 1. JAMA Onco…

Connecting the dots before MHRA approval, 2 Peer reviewed publications and production ready to go! $NWBO🤟😄 1. JAMA Oncology-Peer reviewed👍 2. Nature- Peer reviewed👍 3. Install Flaskworks automated production facility👍 https://t.co/VM8OrZGiT2 https://t.c

@ShylaThom97421 @JamesPe11062557 @scooterd_speaks @B_Rizzly @peter_brit https://t.co/SIpKCTSOBe Same.

@EdKrassen Thanks for shining light on this critical cancer project. Pls see this recent successful phase3 brain cancer vaccine DCVax-L developed by small US Biotech NWBO, currently being vetted for approval but in the UK. Folks need to be aware of it. Thx

@Ned_Nosurname @exosome @KryptyPop @Boomchrisy JAMA don't think so.. https://t.co/UyXkSm44bN

RT @johnlane45: $NWBO #DCVax

RT @RIP_GOP1234: Preach! 🙌🏽👏🏽

RT @RIP_GOP1234: Preach! 🙌🏽👏🏽

Preach! 🙌🏽👏🏽

RT @johnlane45: $NWBO #DCVax

RT @johnlane45: $NWBO #DCVax

RT @johnlane45: $NWBO #DCVax

RT @flaskworks: @Siobhain_Mc @braintumourrsch @BrainTumourOrg @BrainAppeal @CR_UK @DHSCgovuk Cure will come from @NorthwestBio @UCLANsgy Dr…

RT @flaskworks: @Siobhain_Mc @braintumourrsch @BrainTumourOrg @BrainAppeal @CR_UK @DHSCgovuk Cure will come from @NorthwestBio @UCLANsgy Dr…

$NWBO #DCVax

@tradrjoze @JamesPe11062557 @sparky6871 https://t.co/SIpKCTSOBe Even JAMA agrees. DCVAX is ALT-DC Commercially manufactured by $NWBO Soon to the world. Now f*ck off. 🖕🏽😎 https://t.co/e6L4ONTPq1

RT @flaskworks: @Siobhain_Mc @braintumourrsch @BrainTumourOrg @BrainAppeal @CR_UK @DHSCgovuk Cure will come from @NorthwestBio @UCLANsgy Dr…

RT @flaskworks: @Siobhain_Mc @braintumourrsch @BrainTumourOrg @BrainAppeal @CR_UK @DHSCgovuk Cure will come from @NorthwestBio @UCLANsgy Dr…

RT @flaskworks: @Siobhain_Mc @braintumourrsch @BrainTumourOrg @BrainAppeal @CR_UK @DHSCgovuk Cure will come from @NorthwestBio @UCLANsgy Dr…

RT @flaskworks: @Siobhain_Mc @braintumourrsch @BrainTumourOrg @BrainAppeal @CR_UK @DHSCgovuk Cure will come from @NorthwestBio @UCLANsgy Dr…

@Siobhain_Mc @braintumourrsch @BrainTumourOrg @BrainAppeal @CR_UK @DHSCgovuk Cure will come from @NorthwestBio @UCLANsgy Dr Linda Liau using $NWBO DCVax, Keytruda, PolyICLC. https://t.co/UbQi4GbIF9 https://t.co/NDF2KDCG6C With nontoxic therapies tumor s

$nwbo civil spoofing case w underlying naked shorting 3000 FTD’s Also they FLIPPED the SDNY #aviperry lawyer (who’d prosecuted Harrington) & is now working the defense?! Proven #jama cure for GBM cancer plus #allhardtumors #gbm https://t.co/4tfnBnRRy

RT @alphavestcap: $nwbo @alphavestcap https://t.co/RnK1abZe1Q $nwbo @alphavestcap (https://t.co/bhUDKROm2Z…) says "This phase 3, nonran…

RT @alphavestcap: $nwbo @alphavestcap https://t.co/RnK1abZe1Q $nwbo @alphavestcap (https://t.co/bhUDKROm2Z…) says "This phase 3, nonran…

@VivekSubbiah @NEJM Why would CAR-T be preferable option to DCVax which targets all antigens and neoantigens on the heterogeneous Glioblastoma tumor while doesn't induce cytokine storms? https://t.co/UbQi4GcguH

RT @alphavestcap: $nwbo @alphavestcap https://t.co/RnK1abZe1Q $nwbo @alphavestcap (https://t.co/bhUDKROm2Z…) says "This phase 3, nonran…

$nwbo @alphavestcap https://t.co/RnK1abZe1Q $nwbo @alphavestcap (https://t.co/bhUDKROm2Z…) says "This phase 3, nonrandomized, externally controlled trial found that the addition of DCVax-L to SOC was associated with a clinically meaningful and statisti

$nwbo @alphavestcap https://t.co/RnK1abZe1Q $nwbo @alphavestcap (https://t.co/bhUDKROm2Z…) says "This phase 3, nonrandomized, externally controlled trial found that the addition of DCVax-L to SOC was associated with a clinically meaningful and statisti

$nwbo @alphavestcap https://t.co/RnK1abZe1Q $nwbo @alphavestcap (https://t.co/bhUDKROm2Z…) says "This phase 3, nonrandomized, externally controlled trial found that the addition of DCVax-L to SOC was associated with a clinically meaningful and statisti

$nwbo @alphavestcap https://t.co/RnK1abZe1Q $nwbo @alphavestcap (https://t.co/bhUDKROm2Z…) says "This phase 3, nonrandomized, externally controlled trial found that the addition of DCVax-L to SOC was associated with a clinically meaningful and statisti

https://t.co/RnK1abZe1Q $nwbo @alphavestcap (https://t.co/bhUDKROm2Z…) says "This phase 3, nonrandomized, externally controlled trial found that the addition of DCVax-L to SOC was associated with a clinically meaningful and statistically significant exte

$nwbo @alphavestcap @EAntonioChiocca (https://t.co/zla7ZiMHuv) says dc vax l trial is a failure based on PFS . (https://t.co/bhUDKROm2Z) says "This phase 3, nonrandomized, externally controlled trial found that the addition of DCVax-L to SOC was associa

RT @rsloftx: @ChuckCallesto $DCVax by $nwbo to be approved by MHRA in the UK shortly and the phase 3 results reported in JAMA Oncology in N…

RT @rsloftx: @ChuckCallesto $DCVax by $nwbo to be approved by MHRA in the UK shortly and the phase 3 results reported in JAMA Oncology in N…

RT @rsloftx: @ChuckCallesto $DCVax by $nwbo to be approved by MHRA in the UK shortly and the phase 3 results reported in JAMA Oncology in N…

RT @rsloftx: @ChuckCallesto $DCVax by $nwbo to be approved by MHRA in the UK shortly and the phase 3 results reported in JAMA Oncology in N…

@ChuckCallesto $DCVax by $nwbo to be approved by MHRA in the UK shortly and the phase 3 results reported in JAMA Oncology in Nov '22. You can also learn about their MM HF spoofing lawsuit against @Citadel and others via Cohen Milstein lawfirm. https://t.

https://t.co/xSutNbHxTS $nwbo @alphavestcap

@hayleyinvests December 2023 @NorthwestBio submits MAA application for treating Glioblastoma. https://t.co/PHwFvBh4vb Despite amazing results $NWBO remains heavily manipulated stock. https://t.co/UbQi4GbIF9 https://t.co/dLGtjeV7bR Longs see the Amazon

RT @andrewcaravello: #DCVax is the only personalized cancer vaccine platform that has a successful phase III trial that spans decades. $NWB…

RT @alphavestcap: @andrewcaravello $nwbo @alphavestcap #DCVax is the only personalized cancer vaccine platform that has a successful phas…

RT @alphavestcap: @andrewcaravello $nwbo @alphavestcap #DCVax is the only personalized cancer vaccine platform that has a successful phas…

@andrewcaravello $nwbo @alphavestcap #DCVax is the only personalized cancer vaccine platform that has a successful phase III trial that spans decades. $NWBO #AllSolidTumors #NoSideAffects #ItsANoBrainer #CancerMoonShot https://t.co/bhUDKROm2Z

RT @andrewcaravello: #DCVax is the only personalized cancer vaccine platform that has a successful phase III trial that spans decades. $NWB…

RT @andrewcaravello: #DCVax is the only personalized cancer vaccine platform that has a successful phase III trial that spans decades. $NWB…

RT @andrewcaravello: #DCVax is the only personalized cancer vaccine platform that has a successful phase III trial that spans decades. $NWB…

RT @andrewcaravello: #DCVax is the only personalized cancer vaccine platform that has a successful phase III trial that spans decades. $NWB…

RT @andrewcaravello: #DCVax is the only personalized cancer vaccine platform that has a successful phase III trial that spans decades. $NWB…

RT @andrewcaravello: #DCVax is the only personalized cancer vaccine platform that has a successful phase III trial that spans decades. $NWB…

https://t.co/gAcGlUXZVL $nwbo @alphavestcap

RT @andrewcaravello: #DCVax is the only personalized cancer vaccine platform that has a successful phase III trial that spans decades. $NWB…

RT @andrewcaravello: #DCVax is the only personalized cancer vaccine platform that has a successful phase III trial that spans decades. $NWB…

#DCVax is the only personalized cancer vaccine platform that has a successful phase III trial that spans decades. $NWBO #AllSolidTumors #NoSideAffects #ItsANoBrainer #CancerMoonShot https://t.co/hRKyehHT1i

@StockMarketNerd @NorthwestBio https://t.co/UbQi4GbIF9

@donlemon She needs DCVax @KingsCollegeLon https://t.co/UbQi4GbIF9 https://t.co/7ddSAoPCzp https://t.co/5Bv4gutaVe

@MikePhi46301694 @mattkolleck1 @Nina_kd @d_stock07734 https://t.co/V86zey58Hi Prespecified endpoints met with stat significance- the definition of a successful trial. Published here: 🙂

@alphavestcap $nwbo https://t.co/lvShoIM2E8 https://t.co/DL1GDlx8BB https://t.co/UvbfVeADmA https://t.co/cbWJ4OcUQO https://t.co/25OhaGFBgJ https://t.co/XBedMQOdvz https://t.co/JYQgIQGVtS https://t.co/Z2RzOU4Sjz https://t.co/JZ2ytlW6DR https://t.

@alphavestcap $nwbo https://t.co/DL1GDlx8BB https://t.co/UvbfVeADmA https://t.co/cbWJ4OcUQO https://t.co/25OhaGFBgJ https://t.co/XBedMQOdvz https://t.co/JYQgIQGVtS https://t.co/Z2RzOU4Sjz https://t.co/JZ2ytlW6DR https://t.co/tQzS4SawnD https://t.

RT @alphavestcap: https://t.co/NFLd7NPhPh @alphavestcap $nwbo https://t.co/Sn9liYLIap https://t.co/bhUDKROm2Z https://t.co/MTNivDXzFu http…

https://t.co/NFLd7NPhPh @alphavestcap $nwbo https://t.co/Sn9liYLIap https://t.co/bhUDKROm2Z https://t.co/MTNivDXzFu https://t.co/aHhf0zrUGn https://t.co/rlJJOgy1Ej https://t.co/gXASnJvugw https://t.co/gXASnJvugw Bear:By 7/1/24 NWBO’s dc vax L should have

https://t.co/NFLd7NPhPh @alphavestcap $nwbo https://t.co/Sn9liYLIap https://t.co/bhUDKROm2Z https://t.co/MTNivDXzFu https://t.co/aHhf0zrUGn https://t.co/rlJJOgy1Ej https://t.co/gXASnJvugw https://t.co/gXASnJvugw

https://t.co/NFLd7NPhPh @alphavestcap $nwbo https://t.co/Sn9liYLIap https://t.co/bhUDKROm2Z https://t.co/MTNivDXzFu

https://t.co/NFLd7NPhPh @alphavestcap $nwbo https://t.co/Sn9liYLIap https://t.co/bhUDKROm2Z

RT @sharpie510: $NWBO published #DCVax-L results on Nov 17, 2022. Statistically significant extension of mOS for BOTH new and recurrent #gb…

RT @sharpie510: $NWBO published #DCVax-L results on Nov 17, 2022. Statistically significant extension of mOS for BOTH new and recurrent #gb…

RT @sharpie510: $NWBO published #DCVax-L results on Nov 17, 2022. Statistically significant extension of mOS for BOTH new and recurrent #gb…

$NWBO published #DCVax-L results on Nov 17, 2022. Statistically significant extension of mOS for BOTH new and recurrent #gbm! 💪 Patients have been hoping for approval. 547 patients die EVERY DAY from #glioblastoma worldwide. 🙏 https://t.co/NtsI06bbmg htt

@MikePhi46301694 @jcwshankit @peter_brit @andrewcaravello See: https://t.co/V86zey5GwQ

RT @KauriCapital: @GavinPrestonMD #DcVax by $NWBO @NorthwestBio is missing from 2023 breakthroughs https://t.co/Ji7W5ADn9h…

@GavinPrestonMD #DcVax by $NWBO @NorthwestBio is missing from 2023 breakthroughs https://t.co/Ji7W5ADn9h https://t.co/kBn2SY7mGP

Now look at the DCVax-L P3 trial https://t.co/ERNiu12gIg Go to grants and funding at the bottom and here is the same grant. Click it. https://t.co/kAXaziXI9m

RT @flaskworks: @hoffmann6383 @Edpilkington Journalistic malpractice: "Perhaps the most shocking finding of all was that brain cancer clin…

@hoffmann6383 @Edpilkington Journalistic malpractice: "Perhaps the most shocking finding of all was that brain cancer clinical trial completion rates have significantly decreased — from 78% to 64%. In short: we are going backwards." Forgot $NWBO's stat

RT @sharpie510: @mukund https://t.co/ecRzVWneCT

RT @rago_carlo: These cancer vaccine results are breathtaking! rGBM 2yr survival ~10%, Physician's Choice, i.e. "SOC" ~20%, DCVax-L + "SOC…

RT @rago_carlo: These cancer vaccine results are breathtaking! rGBM 2yr survival ~10%, Physician's Choice, i.e. "SOC" ~20%, DCVax-L + "SOC…

@mukund https://t.co/ecRzVWneCT